Aims and Scope of Drug Discovery Today
Drug Discovery Today is a monthly peer-reviewed scientific journal that is published by Elsevier. It was established in 1996 and publishes reviews on all aspects of preclinical drug discovery from target identification and validation through hit identification, lead identification and optimisation, to candidate selection. Less
Key Metrics
CiteScore 

14.7
Eigenfactor 

0.01 - 0.05
Impact Factor 

5 - 10
SJR 

Q1Pharmacology

SNIP 

1.92
Recommended pre-submission checks
Powered by 

Topics Covered on Drug Discovery Today
Drug Discovery Today Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | ELSEVIER SCI LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1996 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Drug Discovery Today ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Drug Discovery Today
From bespoke CRISPR to scalable access: regulating N-of-1 medicines as platforms.
- 8 May 2026
- Drug discovery today
Differential immunogenicity of biosimilar monoclonal antibodies: overrated and overemphasized?
- 8 May 2026
- Drug discovery today
Benign-by-design chemistry: Reinventing ligand-based drug design at the edge of AI.
- 7 May 2026
- Drug discovery today
Biomedical applications of mannan conjugates.
- 7 May 2026
- Drug discovery today
Ligand trapping as a key mechanism governing drug residence time, binding affinity, and potency.
- 6 May 2026
- Drug discovery today
Health and Medical Research in Australia I: A Long-term Investment that Drives Innovation and Endogenous Growth.
- 6 May 2026
- Drug discovery today
From bespoke CRISPR to scalable access: regulating N-of-1 medicines as platforms.
- 8 May 2026
- Drug discovery today
Differential immunogenicity of biosimilar monoclonal antibodies: overrated and overemphasized?
- 8 May 2026
- Drug discovery today
Benign-by-design chemistry: Reinventing ligand-based drug design at the edge of AI.
- 7 May 2026
- Drug discovery today
Biomedical applications of mannan conjugates.
- 7 May 2026
- Drug discovery today
Ligand trapping as a key mechanism governing drug residence time, binding affinity, and potency.
- 6 May 2026
- Drug discovery today
Health and Medical Research in Australia I: A Long-term Investment that Drives Innovation and Endogenous Growth.
- 6 May 2026
- Drug discovery today